A citation-based method for searching scientific literature

Yongliang Zhang, Yu Yao, Yaping Xu, Lifeng Li, Yan Gong, Kai Zhang, Meng Zhang, Yanfang Guan, Lianpeng Chang, Xuefeng Xia, Lin Li, Shuqin Jia, Qiang Zeng. Nat Commun 2021
Times Cited: 6







List of co-cited articles
9 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Nicholas C Turner, Belinda Kingston, Lucy S Kilburn, Sarah Kernaghan, Andrew M Wardley, Iain R Macpherson, Richard D Baird, Rebecca Roylance, Peter Stephens, Olga Oikonomidou,[...]. Lancet Oncol 2020
33
33

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.
Tim Forshew, Muhammed Murtaza, Christine Parkinson, Davina Gale, Dana W Y Tsui, Fiona Kaper, Sarah-Jane Dawson, Anna M Piskorz, Mercedes Jimenez-Linan, David Bentley,[...]. Sci Transl Med 2012
778
33

Detection of circulating tumor DNA in early- and late-stage human malignancies.
Chetan Bettegowda, Mark Sausen, Rebecca J Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R Bartlett, Hao Wang, Brandon Luber, Rhoda M Alani,[...]. Sci Transl Med 2014
33

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.
Aaron M Newman, Scott V Bratman, Jacqueline To, Jacob F Wynne, Neville C W Eclov, Leslie A Modlin, Chih Long Liu, Joel W Neal, Heather A Wakelee, Robert E Merritt,[...]. Nat Med 2014
33

Very Short Mitochondrial DNA Fragments and Heteroplasmy in Human Plasma.
Ruoyu Zhang, Kiichi Nakahira, Xiaoxian Guo, Augustine M K Choi, Zhenglong Gu. Sci Rep 2016
29
33

Analysis of circulating tumor DNA to monitor metastatic breast cancer.
Sarah-Jane Dawson, Dana W Y Tsui, Muhammed Murtaza, Heather Biggs, Oscar M Rueda, Suet-Feung Chin, Mark J Dunning, Davina Gale, Tim Forshew, Betania Mahler-Araujo,[...]. N Engl J Med 2013
33

Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients.
Lindsey M Charo, Ramez N Eskander, Ryosuke Okamura, Sandip P Patel, Mina Nikanjam, Richard B Lanman, David E Piccioni, Shumei Kato, Michael T McHale, Razelle Kurzrock. Mol Oncol 2021
4
50

Enhanced detection of circulating tumor DNA by fragment size analysis.
Florent Mouliere, Dineika Chandrananda, Anna M Piskorz, Elizabeth K Moore, James Morris, Lise Barlebo Ahlborn, Richard Mair, Teodora Goranova, Francesco Marass, Katrin Heider,[...]. Sci Transl Med 2018
248
33

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.
Jane Goodall, Joaquin Mateo, Wei Yuan, Helen Mossop, Nuria Porta, Susana Miranda, Raquel Perez-Lopez, David Dolling, Dan R Robinson, Shahneen Sandhu,[...]. Cancer Discov 2017
198
33

Subclonal diversification of primary breast cancer revealed by multiregion sequencing.
Lucy R Yates, Moritz Gerstung, Stian Knappskog, Christine Desmedt, Gunes Gundem, Peter Van Loo, Turid Aas, Ludmil B Alexandrov, Denis Larsimont, Helen Davies,[...]. Nat Med 2015
431
16

Prognostic and predictive biomarkers in breast cancer: Past, present and future.
Andrea Nicolini, Paola Ferrari, Michael J Duffy. Semin Cancer Biol 2018
126
16

Precision medicine for metastatic breast cancer--limitations and solutions.
Monica Arnedos, Cecile Vicier, Sherene Loi, Celine Lefebvre, Stefan Michiels, Herve Bonnefoi, Fabrice Andre. Nat Rev Clin Oncol 2015
165
16

[Epidemiology and diagnosis of breast cancer].
Agnieszka Budny, Elżbieta Starosławska, Bożena Budny, Rafał Wójcik, Michał Hys, Piotr Kozłowski, Witold Budny, Agnieszka Brodzik, Franciszek Burdan. Pol Merkur Lekarski 2019
2
50

Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of Cancer.
Kelly C S Oliveira, Iago Barroso Ramos, Jessica M C Silva, Williams Fernandes Barra, Gregory J Riggins, Vikrant Palande, Catarina Torres Pinho, Milana Frenkel-Morgenstern, Sidney E B Santos, Paulo P Assumpcao,[...]. Mol Cancer Res 2020
15
16

Metastatic Breast Cancer.
Olive Peart. Radiol Technol 2017
38
16


Circulating-tumor DNA as an early detection and diagnostic tool.
Timothy M Butler, Paul T Spellman, Joe Gray. Curr Opin Genet Dev 2017
41
16

Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies.
Lena Gorgannezhad, Muhammad Umer, Md Nazmul Islam, Nam-Trung Nguyen, Muhammad J A Shiddiky. Lab Chip 2018
107
16

Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.
H Gilbert Welch, David H Gorski, Peter C Albertsen. N Engl J Med 2015
115
16

Breast Cancer Screening Programmes across the WHO European Region: Differences among Countries Based on National Income Level.
Emma Altobelli, Leonardo Rapacchietta, Paolo Matteo Angeletti, Luca Barbante, Filippo Valerio Profeta, Roberto Fagnano. Int J Environ Res Public Health 2017
36
16


Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?
Giuseppe Buono, Lorenzo Gerratana, Michela Bulfoni, Nicoletta Provinciali, Debora Basile, Mario Giuliano, Carla Corvaja, Grazia Arpino, Lucia Del Mastro, Sabino De Placido,[...]. Cancer Treat Rev 2019
45
16

Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment.
Natalja Eigeliene, Jatta Saarenheimo, Antti Jekunen. Oncology 2019
7
16

Breast Cancer Epidemiology, Prevention, and Screening.
Stella Winters, Charmaine Martin, Daniel Murphy, Navkiran K Shokar. Prog Mol Biol Transl Sci 2017
113
16

Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets.
Yiran Liang, Hanwen Zhang, Xiaojin Song, Qifeng Yang. Semin Cancer Biol 2020
29
16

Circulating tumor DNA as an early cancer detection tool.
Andrea Campos-Carrillo, Jeffrey N Weitzel, Prativa Sahoo, Russell Rockne, Janet V Mokhnatkin, Muhammed Murtaza, Stacy W Gray, Laura Goetz, Ajay Goel, Nicholas Schork,[...]. Pharmacol Ther 2020
17
16

Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer.
Xianyu Zhang, Weiwei Zhao, Wei Wei, Zilong You, Xiaohua Ou, Mingming Sun, Yanling Yin, Xiaoyan Tang, Zhen Zhao, Changming Hu,[...]. Clin Cancer Res 2019
17
16


Breast cancer: Tracking ctDNA to evaluate relapse risk.
Diana Romero. Nat Rev Clin Oncol 2015
5
20

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.
Isaac Garcia-Murillas, Gaia Schiavon, Britta Weigelt, Charlotte Ng, Sarah Hrebien, Rosalind J Cutts, Maggie Cheang, Peter Osin, Ashutosh Nerurkar, Iwanka Kozarewa,[...]. Sci Transl Med 2015
600
16


Diagnosis and surgical treatment of breast cancer.
Juliann Reiland-Smith. S D Med 2010
3
33

Application of Cell-free DNA Analysis to Cancer Treatment.
Ryan B Corcoran, Bruce A Chabner. N Engl J Med 2018
257
16

Breast Cancer: Current Perspectives on the Disease Status.
Mohammad Fahad Ullah. Adv Exp Med Biol 2019
59
16


Genomic profile of advanced breast cancer in circulating tumour DNA.
Belinda Kingston, Rosalind J Cutts, Hannah Bye, Matthew Beaney, Giselle Walsh-Crestani, Sarah Hrebien, Claire Swift, Lucy S Kilburn, Sarah Kernaghan, Laura Moretti,[...]. Nat Commun 2021
2
50

The potential of ctDNA analysis in breast cancer.
Eleni Tzanikou, Evi Lianidou. Crit Rev Clin Lab Sci 2020
4
25

Review ctDNA and Breast Cancer.
Florian Clatot. Recent Results Cancer Res 2020
6
16

Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer.
Yidong Zhou, Yaping Xu, Yuhua Gong, Yanyan Zhang, Yaping Lu, Changjun Wang, Ru Yao, Peng Li, Yanfang Guan, Jiayin Wang,[...]. Mol Oncol 2019
12
16

ctDNA as a cancer biomarker: A broad overview.
Luciana Santos Pessoa, Manoela Heringer, Valéria Pereira Ferrer. Crit Rev Oncol Hematol 2020
8
16

Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer.
Daniel Fernandez-Garcia, Allison Hills, Karen Page, Robert K Hastings, Bradley Toghill, Kate S Goddard, Charlotte Ion, Olivia Ogle, Anna Rita Boydell, Kelly Gleason,[...]. Breast Cancer Res 2019
24
16

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer.
Fei Ma, Yanfang Guan, Zongbi Yi, Lianpeng Chang, Qiao Li, Shanshan Chen, Wenjie Zhu, Xiuwen Guan, Chunxiao Li, Haili Qian,[...]. Int J Cancer 2020
24
16

Clinical practice guidelines in breast cancer.
N Kumar Tyagi, S Dhesy-Thind. Curr Oncol 2018
26
16

Liquid biopsy in breast cancer: A comprehensive review.
Sahar Alimirzaie, Maryam Bagherzadeh, Mohammad R Akbari. Clin Genet 2019
58
16

Cell-free circulating tumor DNA in cancer.
Zhen Qin, Vladimir A Ljubimov, Cuiqi Zhou, Yunguang Tong, Jimin Liang. Chin J Cancer 2016
71
16

Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade.
Qu Zhang, Jia Luo, Song Wu, Han Si, Chen Gao, Wenjing Xu, Shaad E Abdullah, Brandon W Higgs, Phillip A Dennis, Michiel S van der Heijden,[...]. Cancer Discov 2020
31
16

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival.
M J M Magbanua, L B Swigart, H-T Wu, G L Hirst, C Yau, D M Wolf, A Tin, R Salari, S Shchegrova, H Pawar,[...]. Ann Oncol 2021
11
16


Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade.
Evan J Lipson, Victor E Velculescu, Theresa S Pritchard, Mark Sausen, Drew M Pardoll, Suzanne L Topalian, Luis A Diaz. J Immunother Cancer 2014
132
16

Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression.
Etienne Giroux Leprieur, Zofia Hélias-Rodzewicz, Paul Takam Kamga, Adrien Costantini, Catherine Julie, Alexandre Corjon, Coraline Dumenil, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune,[...]. J Immunother Cancer 2020
7
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.